Final Trades: Amgen, Exxon, Illinois Tool Works & more
The "Halftime Report" traders give their top picks to watch for the second half....…
Börse:
249,813$
-0,31%
Echtzeit-Aktienkurs Amgen Inc.
Bid:
249,268$
Ask:
250,359$
Nachrichten zur Amgen Inc. Aktie
The Zacks Analyst Blog Highlights Coca-Cola, Oracle, Morgan Stanley, Amgen and TotalEnergies
Coca-Cola, Oracle, Morgan Stanley, Amgen and TotalEnergies are included in this Analyst Blog....…
Marktanteil von Biosimilars wächst - ohne Substitution in der Apotheke
Amgen GmbH: München (ots) - - Marktanteil bei 60 Prozent: Biosimilars bestehen im Wettbewerb - Automatische Substitution in Apotheken: Risiken…
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 3.82% on an annualized basis producing an average…
The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals
Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog....…
Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
...By Michael Erman
NEW YORK (Reuters) - The U.S. Senate Finance... a copy of the letter to…
Amgen: Anlagevotum bestätigt
Minneapolis (www.aktiencheck.de) - Rating-Update:
Christopher Raymond, Analyst von Piper Sandler, stuft die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…
Wednesday’s Top Analyst Upgrades and Downgrades: Amgen, Coinbase, Micron Technology, Nvidia, Roku, Take-Two Interactive and More
Wednesdays top analyst upgrades and downgrades included Amgen, Bed Bath & Beyond, Carlyle, Coinbase Global, Enovix, GoodRx, Healthcare Realty Trust,…
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of…
AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022
Phase 1 Tarlatamab Study Showed Encouraging Antitumor Activity With Median Duration of Response of 13 Months in Small Cell Lung…
Mirati gains as Amgen posts new combination data for rival cancer drug
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amgen: Übernahme-Karussell bleibt in Schwung - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Amgen-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…
Biotech-Branche im Übernahmefieber: Amgen greift nach InflaRx-Konkurrenten
Das Übernahme-Karussell – wie vom AKTIONÄR erwartet – bleibt im Biotech-Sektor in Schwung. Vergangene Woche hat der Biotech-Gigant Amgen zugeschlagen…
Amgen data for new cancer agent shows liver toxicity with immunotherapies
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Biotech Report: Pelosis Taiwan-Reise belastet Märkte, Evotec (EVT) gegen den Trend gesucht
Biotech-Aktien zeigen sich im deutschen Handel uneinheitlich. Papiere von Evotec und Biontech legen zu, während MorphoSys und BB Biotech…
AMGEN DATA AT WCLC 2022 HIGHLIGHTS POTENTIAL TO DELIVER TRANSFORMATIVE MEDICINES FOR HISTORICALLY DIFFICULT-TO-TREAT LUNG CANCERS
First Data From LUMAKRAS Plus Immunotherapy and LUMAKRAS Plus SHP2 Inhibitor Combinations Show Clinical Activity and Support Ongoing Investigation Updated…
Amgen says Lumakras plus immunotherapy for lung cancer needs further study
...By Deena Beasley
(Reuters) - A small study of Amgen Incs... investigator, told Reuters. "There still seems…
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
Amgen (AMGN) beats Q2 estimates for earnings and sales. It offers to buy ChemoCentryx (CCXI) for $3.7 billion....…
+++ Geschäftszahlen im Newsblog +++: Fernsehkonzern RTL senkt Ausblick – Höhere Kosten drücken Gewinn bei Carl Zeiss Meditec
Gewinnsprung bei Aurubis +++ Amgen überrascht mit starken Produktverkäufen +++ Warner Bros meldet deutlichen Quartalsverlust +++ Die Geschäftszahlen des Tages....…
Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates
Amgen (AMGN) delivered earnings and revenue surprises of 5.68% and 0.77%, respectively, for the quarter ended June 2022. Do the…
Amgen überrascht mit starken Produktverkäufen
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank starker Medikamentenverkäufe im zweiten Quartal mehr verdient und umgesetzt als Experten…
Amgen überrascht mit starken Produktverkäufen
THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hat dank starker Medikamentenverkäufe im zweiten Quartal mehr…
Amgen Inc. Announces Increase In Q2 Profit
THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN) revealed earnings for its second quarter that increased from the same period last…
ChemoCentryx Shares up 110%, Amgen Agrees to Acquire Co.
ChemoCentryx Shares up 110%, Amgen Agrees to Acquire Co....…
Shareholder Alert: Ademi LLP investigates whether ChemoCentryx, Inc. has obtained a Fair Price in its transaction with Amgen
MILWAUKEE, Aug. 4, 2022 /PRNewswire/ -- Ademi LLP is investigating ChemoCentryx (NASDAQ: CCXI) for possible breaches of fiduciary duty and…
Amgen To Buy TAVNEOS Developer ChemoCentryx In $3.7 Bln Cash Deal
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) Thursday said it has entered into a definitive agreement to acquire ChemoCentryx, Inc., (CCXI),…
Amgen Acquires Drugmaker ChemoCentryx for $3.7 Billion
With the acquisition, the biotech company adds a newly approved drug for an autoimmune disorder....…
ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal >CCXI
ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal >CCXI...…
ChemoCentryx soars 109% as Amgen agrees to buy for $3.7B in cash
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amgen to gain rare-disease drug in $3.7 billion acquisition of ChemoCentryx
Amgen Inc. said Thursday it plans to buy ChemoCentryx Inc. for $3.7 billion in cash. The deal will…
UPDATE 1-Amgen to buy ChemoCentryx for $3.7 billion
...(Adds details on deal)
Aug 4 (Reuters) - Amgen Inc said on Thursday......…
Amgen declares $1.94 dividend
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AMGEN TO WEBCAST INVESTOR MEETING AT WCLC 2022
THOUSAND OAKS, Calif., Aug. 2, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will host a webcast call for the investment community…
Amgen Fights IRS Over $10.7 Billion Tax Bill
Amgen is fighting a $10.7 billion tax bill from the IRS, which says the biotech improperly shifted nearly $24 billion…
Amgen disputes IRS over $10.7B tax bill - WSJ
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report
read more...…
, Amgen in clinical trial deal for small molecule cancer agent
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
IDEAYA Announces Clinical Trial Collaboration with Amgen to Evaluate MAT2A-PRMT5 Synthetic Lethality Combination in MTAP Deleted Tumors
Entered into Clinical Trial Collaboration and Supply Agreement with Amgen to clinically evaluate IDE397, IDEAYAs investigational MAT2A inhibitor, in combination…
Brand Institute Welcomes Former Amgen Associate General Counsel and Executive Director Timothy J. Gaul as Vice President of Intellectual Property Strategy
MIAMI, July 25, 2022 /PRNewswire/ -- Brand Institute is pleased to announce the appointment of Timothy J. Gaul to the…
Erster Bericht über das ehrgeizigste Sequenzierungsprojekt der Welt
deCODE genetics: REYKJAVÍK, Island (ots/PRNewswire) - Wissenschaftler von deCODE genetics, einer Tochtergesellschaft von Amgen, berichten zusammen mit dänischen Kollegen in…
Erster Bericht über das ehrgeizigste Sequenzierungsprojekt der Welt
REYKJAVÍK, Island, 21. Juli 2022 /PRNewswire/ -- Wissenschaftler von deCODE genetics, einer Tochtergesellschaft von Amgen, berichten zusammen mit dänischen Kollegen…
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know
Amgen (AMGN) closed the most recent trading day at $246.63, moving -0.28% from the previous trading session....…
J&J, AbbVie, and Amgen Among Dominant Players in the Plaque Psoriasis Drugs Market | GlobalData Plc
Sales of Remicade, Stelara, and Tremfya cemented J&J as one of the major companies occupying the PsO market Sales of…
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could…
The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum
Eli Lilly, Thermo Fisher Scientific, TotalEnergies, Amgen and Marathon Petroleum have been included in this Analyst Blog....…
Why Amgen (AMGN) Could Beat Earnings Estimates Again
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Amgen (AMGN) Gains As Market Dips: What You Should Know
In the latest trading session, Amgen (AMGN) closed at $247.09, marking a +0.05% move from the previous day....…
Amgen Touts Early Lumakras Combo Data In KRAS Cancer Settings
BMO Capital Markets says that while Amgen Incs (NASDAQ: AMGN) Lumakras (sotorasib) + PD1i data was delayed to the August 7 presentation, it…
Migraine Therapeutics Market Report 2021: Featuring Major Vendors including AbbVie Inc., Amgen Inc. & Eli Lilly and Co.- Technavio
NEW YORK, July 13, 2022 /PRNewswire/ -- The "Migraine Therapeutics Market - Competitive Analysis, Market Dynamics, Impact of COVID-19, Five…
Amgen Lumakras combination data in lung cancer held until August - Reuters
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…